About Styrax
Styrax is a company based in Hyderabad (India) founded in 1995. Styrax has raised $2.75 million across 1 funding round from investors including Arora Life Sciences. The company has 260 employees as of December 07, 2024. Styrax offers products and services including APIs and Intermediates.
- Headquarter Hyderabad, India
- Employees 260 as on 07 Dec, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Styrax Pharma Private Limited
- Jurisdiction Vishakapatnam, Andhra Pradesh, India
-
Annual Revenue
$30.18 M (USD)-6.19as on Mar 31, 2023
-
Net Profit
$979.56 K (USD)1.69as on Mar 31, 2023
-
EBITDA
$2.42 M (USD)-12.2as on Mar 31, 2023
-
Total Equity Funding
$2.75 M (USD)
in 1 rounds
-
Latest Funding Round
$2.75 M (USD), Series A
Jul 25, 2017
- Investors
-
Employee Count
260
as on Dec 07, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Styrax
Styrax offers a comprehensive portfolio of products and services, including APIs and Intermediates.
APIs are produced by Styrax Pharma, including various active pharmaceutical ingredients that are manufactured in accordance with quality standards.
Intermediates are developed by Styrax Pharma for pharmaceutical use, supporting the creation of diverse products in the industry.
Funding Insights of Styrax
Styrax has successfully raised a total of $2.75M through 1 strategic funding round. The most recent funding activity was a Series A round of $2.75 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Styrax
Styrax has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Arora Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified oral drugs are distributed by Arora Life Sciences.
|
Locked | Locked | Locked |
Investor details for Styrax
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Styrax
Investment portfolio details for Styrax
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Styrax
Detailed financials for Styrax
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Styrax Comparisons
Peer comparison for Styrax
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Styrax
Detailed competitors of Styrax
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Styrax
Complete news archive for Styrax
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Styrax
Styrax was founded in 1995 and raised its 1st funding round 22 years after it was founded.
Styrax is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Styrax is a funded company, having raised a total of $2.75M across 1 funding round to date.
As of Dec 07, 2024, the latest employee count at Styrax is 260.
Annual revenue of Styrax is $30.18M as on Mar 31, 2023.
Manufacturer supplier of active pharmaceutical ingredients and intermediates. It offers a diverse range of active pharmaceutical ingredients and intermediates include Abacavir Sulphate, Emtricitabine USP, Lamivudine, Tenofovir Disoproxil Fumarate, Fluconazole, Itraconazole, Levocetirizine Dihydrochloride, Rifaximin, Duloxetine Hydrochloride and Eltrombopag.
Styrax offers APIs and Intermediates.
Styrax has 1 investor. Key investors include Arora Life Sciences.
The valuation of Styrax is $8.8M as of Jul 2017.